Good contact GC has made on LinkedIn in the last day :))
Media Relations Consultant
Mariesa Kemble, d.b.a.
1997 – Present (16 years)
Mariesa has over 20 years experience in securing award-winning global press coverage for numerous energy/clean tech, consumer health, and medical device companies, including some of the world's biopharma industry giants.
Some of these companies include: Abgenix, Advanced Ethanol Council, AGY Therapeutics, Allergan, Amgen, Anesiva, Bausch & Lomb, Bayer, Boston Scientific, Ciphergen, Cord Blood Registry, CV Therapeutics, Dendreon, eValve, FuelChoiceNow, Given Imaging, Genentech, Genomic Health, Glaxo SmithKline, Haemonetics, Harvard Community Health Care, Immune Response Corporation, Intermune, Introgen, Johnson & Johnson, Memory Pharmaceuticals, Medtronic, Myriant, Oncology Therapeutics Network, Onyx, Qteros, Roche Molecular Diagnostics, Scios, Telik, Together Rx, U.S. Surgical, Vicron, Visudyne, and Virologic.
Mariesa consistently delivers high-profile press coverage in such media as Newsweek, Time, US News & World Report, Fortune, Forbes, Forbes.com, Business Week, Good Morning America, Today, NBC Nightly News, CBS Evening News, 20/20, ABC World News Tonight, The New York Times, The Saturday Evening Post, Financial Times, thestreet.com, The Wall Street Journal, Dateline, CNN, Associated Press, Dow Jones, Bloomberg and Reuters.
Mariesa has earned many awards for her work, including the prestigious Clarion award from Women in Communications, for publishing and editing a newsletter that she founded entitled, "MediaQuest, The Behind-The-Scenes Guide to the National Media". MediaQuest has been used as a teaching tool in some of the top communications graduate programs, including the Columbia Graduate School of Journalism.
In addition, she has spearheaded national and international press coverage in public relations campaigns that have brought her repeated Silver Anvil awards for excellence in public relations.
- Forums
- ASX - By Stock
- ADO
- new team member
new team member, page-8
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.28M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $37.13K | 1.752M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 441468 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 668891 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 441468 | 0.021 |
11 | 1943105 | 0.020 |
3 | 2782500 | 0.019 |
7 | 2041613 | 0.018 |
6 | 1674748 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 668891 | 4 |
0.023 | 22000 | 1 |
0.024 | 48550 | 1 |
0.025 | 40000 | 1 |
0.026 | 76000 | 2 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |